Email Updates

You are here

Home

Wits Reproductive Health and HIV Institute

Status
Planned
Phase
Demo Project
Principal Investigator(s)
World Health Organization, UNAIDS, O'Neil Institute of Georgetown University, London School of Hygiene and Tropical Medicine, Imperial College London;
Objective

Aims to assess whether oral PrEP and TasP can be rolled out within a combination prevention and care approach tailored to the needs of 605, both HIV-positive and negative, female sex workers age 18 and older.

Prevention Option(s)
PrEP
Study Design
Controlled
Arms and Assigned Interventions
Description
Aims to assess whether oral PrEP and TasP can be rolled out within a combination prevention and care approach tailored to the needs of 605, both HIV-positive and negative, female sex workers age 18 and older. Study sites include Hillbrow and Waterval Boven.
Mode of Delivery
Tablet
Products
TDF/FTC (Truvada)
ARMs
Experimental
Trial Sponsors
World Health Organization, UNAIDS, O'Neil Institute of Georgetown University, London School of Hygiene and Tropical Medicine, Imperial College London;
Product Developers
Bill and Melinda Foundation
November 2014
Enrollment
605
Population
Women
HIV positive
Sites

Site(s)- South Africa

South Africa